{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:40:41Z","timestamp":1761061241697,"version":"build-2065373602"},"reference-count":57,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T00:00:00Z","timestamp":1471564800000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2016,8]]},"abstract":"<jats:p>Invasive meningococcal disease caused by <jats:italic>Neisseria meningitidis<\/jats:italic> presents a significant public health concern. Meningococcal disease is rare but potentially fatal within 24\u00a0hours of onset of illness, and survivors may experience permanent sequelae. This review presents the epidemiology, incidence, and outbreak data for invasive meningococcal disease in the United States since 1970, and it highlights recent changes in vaccine recommendations to prevent meningococcal disease. Relevant publications were obtained by database searches for articles published between January 1970 and July 2015. The incidence of meningococcal disease has decreased in the United States since 1970, but serogroup B meningococcal disease is responsible for an increasing proportion of disease burden in young adults. Recent serogroup B outbreaks on college campuses warrant broader age\u2010based recommendations for meningococcal group B vaccines, similar to the currently recommended quadrivalent vaccine that protects against serogroups A, C, W, and Y. After the recent approval of two serogroup B vaccines, the Advisory Committee on Immunization Practices first updated its recommendations for routine meningococcal vaccination to cover at\u2010risk populations, including those at risk during serogroup B outbreaks, and later it issued a recommendation for those aged 16\u201323\u00a0years. Meningococcal disease outbreaks remain challenging to predict, making the optimal disease management strategy one of prevention through vaccination rather than containment. How the epidemiology of serogroup B disease and prevention of outbreaks will be affected by the new category B recommendation for serogroup B vaccines remains to be seen.<\/jats:p>","DOI":"10.1002\/phar.1790","type":"journal-article","created":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T17:08:08Z","timestamp":1466615288000},"page":"880-892","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["History of Meningococcal Outbreaks in the United States: Implications for Vaccination and Disease Prevention"],"prefix":"10.1002","volume":"36","author":[{"given":"Bruce","family":"Atkinson","sequence":"first","affiliation":[{"name":"Vaccine Medical Affairs Pfizer Inc. Collegeville Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashesh","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Vaccine Medical Affairs Pfizer Inc. Collegeville Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Balmer","sequence":"additional","affiliation":[{"name":"Vaccine Medical Affairs Pfizer Inc. Collegeville Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,8,19]]},"reference":[{"key":"e_1_2_7_2_1","unstructured":"World Health Organization.Meningococcal Meningitis Fact Sheet No 141. Available fromhttp:\/\/www.who.int\/mediacentre\/factsheets\/fs141\/en\/#;. Accessed August 13 2015."},{"key":"e_1_2_7_3_1","first-page":"1","article-title":"Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"Cohn AC","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_7_4_1","first-page":"1","article-title":"Summary of Notifiable Diseases\u2010United States, 2012","volume":"61","author":"Centers for Disease Control and Prevention","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1086\/649209"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.062"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.32.2.323-330.1994"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70251-6"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1086\/504804"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.02.058"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)67932-4"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-2035"},{"key":"e_1_2_7_13_1","unstructured":"Centers for Disease Control and Prevention.Active Bacterial Core Surveillance (ABCs) Report Emerging Infections Program Network Neisseria meningitidis 2013. Available fromhttp:\/\/www.cdc.gov\/abcs\/reports-findings\/survreports\/mening13.pdf. Accessed March 31 2016."},{"key":"e_1_2_7_14_1","unstructured":"Oregon Health Authority.Communicable Disease Annual Report 2013. Available fromhttps:\/\/public.health.oregon.gov\/DiseasesConditions\/CommunicableDisease\/DiseaseSurveillanceData\/AnnualReports\/Documents\/2013\/2013-menin.pdf. Accessed July 27 2016."},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.22302"},{"key":"e_1_2_7_16_1","unstructured":"MacNeilJ.Considerations for routine use of serogroup B meningococcal (MenB) vaccines in adolescents. Available from\u00a0http:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/min-archive\/min-2015-06.pdf. Accessed July 27 2016."},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu842"},{"key":"e_1_2_7_18_1","unstructured":"MacNeilJ.Epidemiology of serogroup B meningococcal disease United States. Available fromhttp:\/\/www.nitag-resource.org\/uploads\/media\/default\/0001\/02\/243a06a67d8f4d6c08521e1d486325d2781c8b04.pdf. Accessed July 27 2016."},{"key":"e_1_2_7_19_1","first-page":"606","article-title":"Serogroup B meningococcal disease outbreak and carriage evaluation at a college\u2014Rhode Island, 2015","volume":"64","author":"Soeters HM","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/0009922809347797"},{"key":"e_1_2_7_21_1","first-page":"72","article-title":"Updated recommendations for use of meningococcal conjugate vaccines\u2014Advisory Committee on Immunization Practices (ACIP), 2010","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-160-1-201401070-00731"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181c38f3b"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.9.4811-4814.2005"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268899002368"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.129.6.1327"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1809.120257"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2102.141037"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.6.688"},{"key":"e_1_2_7_30_1","first-page":"1033","article-title":"Serogroup C invasive meningococcal disease among men who have sex with men\u2014New York City, 2010\u20132012","volume":"61","author":"Weiss D","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_7_31_1","unstructured":"California Department of Public Health.Meningococcal Vaccine Recommendations for Men Who Have Sex with Men. Available fromhttp:\/\/www.cdph.ca.gov\/HealthInfo\/discond\/Documents\/MSM_meningococcal_vaccine_health_advisory_April15_2014.pdf. Accessed March 23 2015."},{"key":"e_1_2_7_32_1","unstructured":"Chicago Health Alert Network.Meningococcal Vaccine Recommendations for HIV\u2010positive Individuals. Available fromhttps:\/\/www.chicagohan.org\/mening;jsessionid=26A202153B93BCF32DCEBE782223277B. Accessed September 2015."},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit243"},{"key":"e_1_2_7_34_1","unstructured":"GaronD.From mening to syringe: Outbreak of meningococcal disease at a New Jersey university 2013. Available fromhttps:\/\/www.chicagohan.org\/c\/document-library\/get-file?p-l-id=61826&folderId=88419&name=DLFE-499.pdf. Accessed April 18 2016."},{"key":"e_1_2_7_35_1","unstructured":"SchaffnerW BakerCJ BozofL EngelJ OffitPA TurnerJC.Addressing the challenges of serogroup B meningococcal disease outbreaks on campuses: a report by the National Foundation for Infectious Diseases. Available fromhttp:\/\/www.nfid.org\/meningococcal-b. Accessed July 27 2016."},{"key":"e_1_2_7_36_1","unstructured":"Providence College Health Center.Health advisory February 5 2015. Available fromhttp:\/\/www.providence.edu\/health-center\/Pages\/default.aspx. Accessed October 20 2015."},{"key":"e_1_2_7_37_1","unstructured":"Food and Drug Administration.Accelerated Supplement Approval April 14 2016 (Trumenba two\u2010dose schedule). Available fromhttp:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM496391.pdf. Accessed April 15 2016."},{"key":"e_1_2_7_38_1","doi-asserted-by":"crossref","unstructured":"SoetersHM McNamaraLA WhaleyM et\u00a0al.Meningococcal Carriage Evaluation in Response to a Serogroup B Meningococcal Disease Outbreak and Mass Vaccination Campaign at a College\u2014Rhode Island 2015. Presented at: IDWeek; October 7\u201311 2015;San Diego CA.","DOI":"10.1093\/ofid\/ofv133.1421"},{"key":"e_1_2_7_39_1","unstructured":"University of Oregon.Second vaccination clinic successful say organizers. Available fromhttps:\/\/around.uoregon.edu\/content\/second-vaccination-clinic-successful-says-organizers. Accessed August 13 2015."},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-4015"},{"key":"e_1_2_7_41_1","unstructured":"De WalsP.Results of a mass immunization campaign with 4\u2010components serogroup B meningococcal vaccine (4CMenB) in Quebec Canada. Presented at: The World Society for Pediatric Infectious Diseases (WSPID) November 18\u201321 2015; Rio de Janeiro Brazil."},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1086\/599117"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00304-10"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.27051"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/pit058"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000965"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.10.050"},{"key":"e_1_2_7_48_1","first-page":"527","article-title":"Use of MenACWY\u2010CRM vaccine in children aged 2 through 23\u00a0months at increased risk for meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2013","volume":"63","author":"MacNeil JR","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_7_49_1","first-page":"608","article-title":"Use of serogroup B meningococcal vaccines in persons aged \u226510\u00a0years at increased risk for serogroup B meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2015","volume":"64","author":"Folaranmi T","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6441a3"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00299-7"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.10.5.780-786.2003"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00529-09"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7385.365"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61016-2"},{"key":"e_1_2_7_56_1","first-page":"327","article-title":"New framework (GRADE) for development of evidence\u2010based recommendations by the Advisory Committee on Immunization Practices","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.03.001"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318292f425"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fphar.1790","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/phar.1790","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:58:51Z","timestamp":1761058731000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/phar.1790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["10.1002\/phar.1790"],"URL":"https:\/\/doi.org\/10.1002\/phar.1790","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"type":"print","value":"0277-0008"},{"type":"electronic","value":"1875-9114"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"2016-08-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}